Terms: = Lymphoma AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
50 results:
1. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Blastoid and Pleomorphic Mantle Cell lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features.
Khanlari M; Mo H; Kim DH; Sakhdari A; Young KH; Jain P; Wang M; Li S; Kanagal-Shamanna R; Miranda RN; Vega F; Medeiros LJ; Ok CY
Am J Surg Pathol; 2023 Aug; 47(8):849-858. PubMed ID: 37288826
[TBL] [Abstract] [Full Text] [Related]
4. Statistical Methods Inspired by Challenges in Pediatric Cancer Multi-omics.
Cao X; Elsayed AH; Pounds SB
Methods Mol Biol; 2023; 2629():349-373. PubMed ID: 36929085
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities.
Takakusagi Y; Serizawa I; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Katoh H; Hiruma T; Kamada T
Anticancer Res; 2022 Jul; 42(7):3701-3706. PubMed ID: 35790269
[TBL] [Abstract] [Full Text] [Related]
6. Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell lymphoma: International Metabolic Prognostic Index.
Mikhaeel NG; Heymans MW; Eertink JJ; de Vet HCW; Boellaard R; Dührsen U; Ceriani L; Schmitz C; Wiegers SE; Hüttmann A; Lugtenburg PJ; Zucca E; Zwezerijnen GJC; Hoekstra OS; Zijlstra JM; Barrington SF
J Clin Oncol; 2022 Jul; 40(21):2352-2360. PubMed ID: 35357901
[TBL] [Abstract] [Full Text] [Related]
7. [Expression and Prognostic Value of Metabolism-related Genes in Pediatric Acute Lymphoblastic Leukemia].
Zhang H; Chen J; Ma HZ; Zhao L; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1375-1379. PubMed ID: 34627413
[TBL] [Abstract] [Full Text] [Related]
8. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
Yu L; Shi M; Cai Q; Strati P; Hagemeister F; Zhai Q; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Zhang L; Li J; Oksenhendler E; Xu-Monette ZY; Young KH
Oncologist; 2020 Nov; 25(11):963-973. PubMed ID: 32852137
[TBL] [Abstract] [Full Text] [Related]
9. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.
Xu-Monette ZY; Zhang H; Zhu F; Tzankov A; Bhagat G; Visco C; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; You H; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; van Krieken JH; Piris MA; Winter JN; Hagemeister FB; Shahbaba B; De Dios I; Zhang H; Li Y; Xu B; Albitar M; Young KH
Blood Adv; 2020 Jul; 4(14):3391-3404. PubMed ID: 32722783
[TBL] [Abstract] [Full Text] [Related]
10. A phase III randomized controlled trial of radiation dose optimization in non-Hodgkin lymphoma-diffuse large B-cell lymphoma (DOBL study): Study protocol and design.
Goda JS; Lewis SC; Laskar S; Kannan S; Khanna N; Jain H; Bagal B; Epari S
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1161. PubMed ID: 32935480
[TBL] [Abstract] [Full Text] [Related]
11. Impact of EML4-ALK Variant on Resistance Mechanisms and clinical outcomes in ALK-Positive Lung Cancer.
Lin JJ; Zhu VW; Yoda S; Yeap BY; Schrock AB; Dagogo-Jack I; Jessop NA; Jiang GY; Le LP; Gowen K; Stephens PJ; Ross JS; Ali SM; Miller VA; Johnson ML; Lovly CM; Hata AN; Gainor JF; Iafrate AJ; Shaw AT; Ou SI
J Clin Oncol; 2018 Apr; 36(12):1199-1206. PubMed ID: 29373100
[TBL] [Abstract] [Full Text] [Related]
12. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.
Ji MM; Huang YH; Huang JY; Wang ZF; Fu D; Liu H; Liu F; Leboeuf C; Wang L; Ye J; Lu YM; Janin A; Cheng S; Zhao WL
Haematologica; 2018 Apr; 103(4):679-687. PubMed ID: 29305415
[TBL] [Abstract] [Full Text] [Related]
13. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract] [Full Text] [Related]
14. Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt T; Hufnagl C; Weinstock DM; Kopp N; Neureiter D; Tränkenschuh W; Hackl H; Weiss L; Rinnerthaler G; Hartmann TN; Greil R; Weigert O; Egle A
Oncotarget; 2016 Aug; 7(32):51494-51502. PubMed ID: 27285986
[TBL] [Abstract] [Full Text] [Related]
15. Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell lymphoma.
Xu Q; Tan C; Ni S; Wang Q; Wu F; Liu F; Ye X; Meng X; Sheng W; Du X
Sci Rep; 2015 May; 5():10006. PubMed ID: 25940947
[TBL] [Abstract] [Full Text] [Related]
16. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract] [Full Text] [Related]
17. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan KT; Melchardt T; Deutsch A; Schlick K; Stojakovic T; Bullock MD; Reitz D; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Egle A; Pichler M
Eur J Haematol; 2015 Dec; 95(6):538-44. PubMed ID: 25677782
[TBL] [Abstract] [Full Text] [Related]
18. A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.
Abate F; Todaro M; van der Krogt JA; Boi M; Landra I; Machiorlatti R; Tabbò F; Messana K; Abele C; Barreca A; Novero D; Gaudiano M; Aliberti S; Di Giacomo F; Tousseyn T; Lasorsa E; Crescenzo R; Bessone L; Ficarra E; Acquaviva A; Rinaldi A; Ponzoni M; Longo DL; Aime S; Cheng M; Ruggeri B; Piccaluga PP; Pileri S; Tiacci E; Falini B; Pera-Gresely B; Cerchietti L; Iqbal J; Chan WC; Shultz LD; Kwee I; Piva R; Wlodarska I; Rabadan R; Bertoni F; Inghirami G;
Leukemia; 2015 Jun; 29(6):1390-401. PubMed ID: 25533804
[TBL] [Abstract] [Full Text] [Related]
19. Diffuse large B-cell lymphoma: sub-classification by massive parallel quantitative RT-PCR.
Xue X; Zeng N; Gao Z; Du MQ
Lab Invest; 2015 Jan; 95(1):113-20. PubMed ID: 25418578
[TBL] [Abstract] [Full Text] [Related]
20. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.
Nordlund J; Bäcklin CL; Wahlberg P; Busche S; Berglund EC; Eloranta ML; Flaegstad T; Forestier E; Frost BM; Harila-Saari A; Heyman M; Jónsson OG; Larsson R; Palle J; Rönnblom L; Schmiegelow K; Sinnett D; Söderhäll S; Pastinen T; Gustafsson MG; Lönnerholm G; Syvänen AC
Genome Biol; 2013 Sep; 14(9):r105. PubMed ID: 24063430
[TBL] [Abstract] [Full Text] [Related]
[Next]
